Matt Hoffman
NeurologyLive®
Cranbury, NJ, United States
Contact Matt
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Matt:
FDA Action Update, January 2023: Approvals, Refusals, Clinical Hold Lifts, and Submissions
Catch up on any of the neurology news headlines you may have missed over the course of January 2023, compiled all into one place by the NeurologyLive® team. → Read More
Support, Skepticism, and Statistics: The Aducanumab Saga
After a sudden reversal and complex analyses, aducanumab’s future rests in the hands of the FDA while the community stands split on if the available data are enough to justify an approval. → Read More
Suprachoroidal CLS-TA Proves Effective, Safe in PEACHTREE Trial
Patients who were treated with CLS-TA were able to achieve ≥3 lines of visual acuity 47% of the time, compared to 15% of the patients who received sham treatment. → Read More
FDA Roundup: Cannabidiol Approved as the First Marijuana-Derived, Purified Drug Substance
Catch up on this week's biggest headlines in FDA news. → Read More
FDA Green Lights OsteoDetect, AI-Guided Software for Wrist Fracture Identification
The FDA’s decision was made based on a retrospective analysis of 1000 radiograph images that were used to evaluate the independent enactment of the OsteoDetect AI algorithm. → Read More
FDA Approves Newest Generation of XIENCE Stent for Blockage in CAD
Since its original approval in 2008, more than 8 million patients worldwide have received a XIENCE stent, according to Abbott. → Read More
FDA Clears Pantheris Lumivascular Atherectomy System for PAD Treatment
Avinger stated that it plans to incorporate this next generation version of the device into its ongoing clinical trial program, INSIGHT, an FDA Investigation Device Exemption study. → Read More
Could Pokemon GO, Augmented Reality Apps be Used for Mental Health Therapy?
The use of the popular smartphone application Pokémon GO—and possibly similar games—could have the potential therapeutic benefits for those with mental illness. → Read More
FDA Clears Exact Imaging's FusionVu Application for Its Biopsy Platform
FusionVu allows for the fastest and simplest real-time targeting of prostate biopsies while also providing the highest resolution in real-time guidance for them, according to Exact Imaging. → Read More
FDA Issues CRL to Sandoz for Rituximab Biosimilar
The BLA was originally accepted by the FDA for review in September 2017, with the product intended to be used for the treatment of immunological conditions such as rheumatoid arthritis, as well as blood cancers. → Read More
FDA Clears IN.PACT Admiral DCB, Low-Profile PTA Balloon Catheter for PAD
These devices provide additional treatment options for an often-underdiagnosed condition that impacts 12% to 20% of Americans older than 60. → Read More
Can Nurse Practitioners Fill the Void in Primary Care?
As the number of primary care physicians shrinks, nurse practitioners have a unique opportunity to fill gaps in care. → Read More
FDA Accepts New NDA Submission for ALKS 5461
The NDA acceptance comes just days after the FDA issued a Refusal to File letter to Alkermes for its investigational MDD therapy. → Read More
FDA Announces IDE Trial for Medtronic's Symplicity Spyral Renal Denervation System
The device is approved for commercial use in more than 50 countries but is limited to investigational use in the United States and Japan. → Read More
What is The Pause? Taking a Moment to Address Pain and Profundity
How taking time to reflect after the loss of a patient can help physicians endure everyday loss. → Read More
Sephy Philip, PharmD: The ANCHOR Trial
Sephy Philip, PharmD, discussed the results of the ANCHOR trial, as well as the subgroup analysis. → Read More
FDA Announces Mandatory Kratom Recall Due to Salmonella Contamination
In a first-time issuance, all food products containing powdered kratom from Triangle Pharmanaturals, have been ordered to be recalled due to samples containing salmonella bacteria. → Read More
Is the Threshold for Statistical Significance Too High?
Science has begun to lean on P values as the gold standard for study results, which has led to the misconception that statistical significance equals truth. → Read More
MD or DO: Blurring the Lines between Osteopathic and Allopathic Medicine
Doctors of osteopathic medicine have long sought to be viewed equally in the eyes of their colleagues, but their differences may have helped shape modern medicine. Does stigma still exist? → Read More
SGLT-2 Inhibitors Linked to Lowered Risk of Mortality, MI, Stroke, and Hospitalization for Heart Failure
The CVD-REAL 2 study found that compared with other glucose-lowering drugs, SGLT-2 inhibitors reduce all-cause death, hospitalization for heart failure, myocardial infarction, and stroke. → Read More